Prof. Hermann Luebbert, PhD, is Chief Executive Officer of Biofrontera AG and Managing Director of all its subsidiaries. He studied biology in his native city of Cologne, where he completed a PhD in 1984.
After eight years of academic research at the University of Cologne and the California Institute of Technology (USA), he was awarded the habilitation at the ETH (Eidgenössische Technische Hochschule) Zürich. Prof. Lübbert has held the Chair of Animal Physiology at Ruhr-University Bochum since 1998. During his ten years at Sandoz and Novartis Pharma AG, Prof. Lübbert acquired experience in managing a globally active research organisation.
He founded Biofrontera in 1997 and has since managed the company.
Erica Monaco serves as Chief Financial Officer for Biofrontera Inc. and is responsible for the financial stewardship and operational oversite of finance, operations, legal, compliance and human resources. She joined Biofrontera in 2016 and has accepted progressive positions culminating in her appointment to the Board of Directors of Biofrontera Inc., in January 2020. Erica has provided leadership and has been a key contributor in the success of the United States subsidiary of Biofrontera AG, from the earliest stages including the launch of the flagship products to the development of the business structure, processes and partnerships required to operate and grow the subsidiary into a $25M entity in 3 years. She was integral to the 2018 NASDAQ listing and the 2019 merger and integration of Cutanea Life Sciences. Erica is a Certified Public Accountant bringing 15 years of experience in diverse accounting and financial leadership roles, including audit and tax services with the public accounting firm Deloitte, where she worked with multiple global public companies on diverse projects. She has held corporate finance leadership roles within the pharmaceutical industry and not-for-profit entities, leading teams through accounting system implementations, organizational synergy projects and strategic planning initiatives. Erica received her Bachelor of Business Administration with an Accounting concentration and her Master of Accountancy (M.S.A) from The Isenberg School of Management at the University of Massachusetts.
Biofrontera Inc. is a wholly owned subsidiary of Biofrontera AG. Biofrontera AG has two separate boards of directors, the Supervisory Board and the Management Board. No individual may simultaneously be a member of both boards. The Management Board is responsible for the day-to-day management of all subsidiaries of Biofrontera AG. The principal responsibility of the independent Supervisory Board is to supervise the Management Board as well as to appoint and remove members of the Management Board.